ESR1 and breast cancer: We used the low-input TF profiling method CUT&RUN, which we first validated in MCF-7 breast cancer cells by comparing to a previous dataset for chromatin immunoprecipitation with sequencing (ChIP–seq) of ERα (Extended Data Fig. 1).